[1] 樊嘉，徐泱，周俭，等. 肝癌患者肝移植适应证的选择[J]. 中华医学杂志，2005，85（24）：1662-1664.
[2] ZHENG SS，CHEN YM，LIANGTB，et al. Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B immunoglobulin prophylaxis[J]. Liver Transpl，2006，12（2）:253-258.
[3] STEINMULLER T，SEEHOFER D，RAYES N，et al. Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease[J]. Hepatology，2002， 35（6）:1528-1535.
[4] OMATA M. Significance of extra hepatic replication of hepatitis B virus[J]. Hepatology，1990，12（2）: 364-366.
[5] FANG Q，ZHAO LS，ZHOU TY，et al. Reinfection of HBV and its possible mechanism in patients with liver transplantation[J]. Chin J Hepatol，2005，13（3）:225-227.
[6] ROSENAU J，BAHR MJ，TILLMANN HL，et a1. Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection[J]. Hepatology，2001，34（6）:895-902.
[7] MUTIMER D，PILLAY D，DRAGON E，et al. High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft reinfection after liver transplantation[J]. Hepatology，1999，30（4）:715-721.
[8] MUTIMER D，PILLAY D，SHIELDS P，et al. Outcome of lamivudine resistant hepatitis B virus Infection in the liver transplant recipient[J]. Gut，2000，46（1）:107-113.
[9] KIM KH，LEE KH，CHANG HY，et al. Evolution of hepatitis B virus sequence from a liver transplant recipient with rapid breakthrough despite hepatitis B immune globulin prophylaxis and lamivudine therapy[J]. Med Virol，2003，71（3）:367-375.
[10] MCMASTER P，GUNSON B，MIN X，et al. Liver transplantation:changing goals in immuneosuppression[J]. Transpl Proc，1998，30（5），1819-1821.
[11] HART J，BUSUTTIL RW，LEWIN KJ. Disease recurrance following liver transplantation[J]. AM J Surg Pathol，1990，14（suppl l）:79-91.
[12] 吴元凯，崇雨田. 肝移植后乙型肝炎复发的研究进展[J]. 国外医学内科学分册，2006，3（33）：105-109.
[13] 黄洁夫． 中国肝脏移植[M]． 1版. 北京：人民卫生出版社，2008：562-564．
[14] 王笑梅，兰孟冬，段英，等. 肝移植后乙型肝炎复发的临床表现与预后[J]. 胃肠病学和肝脏病学杂志，2008，17（1）：55-58.
[15] TOD0 S，DEMETRlS A，VAN THIEL D，et a1. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease[J]. Hepatology，199l，13:619-626.
[16] 沈中阳. 肝脏移植术后乙型肝炎复发的综合防治[J]. 中国医学科学院学报，2005，27:431-434.
[17] MOHANTY SR，COTLER SJ. Management of hepatitis B in liver transplant patients[R]. Clin Gastroenterol，2005，39（1）:58-63.
[18] FERRETTI G，MERLI M，ORRADINI SG，et al. Low dose intramuscular hepatitis B immune globulin and lamivudine for long term prophylaxis of hepatitis B recurrence after liver transplantation[J]. Transplant Proc，2004，36（3）: 535-538.
[19] STEINMULLER T，SEEHOFER D，RAYES N，et al. Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease[J]. Hepatoogy，2002， 35（6）:1528-1535.
[20] SEEHOFER D. Preoperative antiviral treatment and postoperative prophyaxis in HBV DNA positive patients undergoing liver transplantation[J]. Liver Transpl，2001，72（8）:1381-1385.
[21] SAAB S，KIM M，WRIGHT TL，et al. Successful orthotopic liver transplantation for lamivudine-associated YMDD mutant hepatitis B virus[J]. Gastroenterology，2000，119（5）:1382-1384.
[22] CHAN HL，CHUI AK，LAU WY，et al. Outcome of lamivudine resistant hepatitis B virus mutant post-liver transplantation on lamivudine monoprophylaxis[J]. Clin Transplant，2004，18（3）:295-300.
[23] 邓青龙，彭志海. 预防肝移植后乙型肝炎复发的治疗现状[J]. 中华实验外科杂志，2006，23（3）：379-380.
[24] 郑俊福，韩大康，李丽，等. 恩替卡韦联合乙型肝炎免疫球蛋白预防肝移植术后乙型肝炎再感染[J]. 世界华人消化杂志，2009，17（7）：716-719.
[25] 蔡常结，赵辉，郭怡，等. 恩替卡韦预防肝移植术后HBV再感染的临床研究[J]. 中华普通外科文献（电子版），2008，2（5）：385-389.
[26] 刘建，吴国聪，张忠涛，等. 肝移植术后乙型肝炎复发的预防和治疗[J]. 中华外科杂志，2005，43（15）：976-979.
[27] GISH RG，MCCASHLAND T. Hepatitis B in liver transplant recipients[R]. Liver Transplant，2006，12（11 Suppl 2）:S54-64.
[28] LOK AS. Prevention of recurrent hepatitis B post liver transplantation[R]. Liver Transpl，2002，8（10 Suppl 1）:S67-73.
[29] LAUCHART W，MULLER R，PICHLMAYR R. Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts[J]. Transplant Proc，1987，19（1 Pt 3）:2387-2389.
[30] CAREY W，PIMENTEL R，WESTVEER MK，et al. Failure of hepatitis B immunization in liver transplant recipients:results of a prospective trial[J]. Am J Gastroenterol， 1990，85（12）:1590-1592.
[31] SANCHEZ-FUEYO A，RIMOLA A，GRANDEL，et al. Hepatitis B Immunoglobulin discontinuation followed by hepatitis B virus vaccination:A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation[J]. Hepatology，2000，31（2）:496-501.
[32] STATKEL P，STOFFEL M，LERYT J，et al. Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients[J]. Liver Transpl，2005，11（10）:1228-1234.
[33] DI PAOLO D，LENCI I，CEROCCHI C，et al. One-year vaccination against hepatitis B virus with a MPL-vaccine in liver transplant patients for HBV-related cirrhosis[J]. Transpl Int，2010，23（11）:1105-1112. |
